Share On

Loading...
PROCESSING. PLEASE WAIT...

"Guide to Health Care Partnerships for Population Health"

Winning Across the Continuum: Partnering for Population Health in a Time of Shifting Reimbursements

Winning Across the Continuum: Partnering for Population Health in a Time of Shifting Reimbursements

White Paper: Athena Health

At varying paces nationally, payment models are shifting from
fee-for-service to fee-for-value, including new models in which
leading provider organizations take on the financial risk of providing
health care to a pre-defined population. While many agree that
value-based reimbursement will become increasingly common,
fee-for-service contracts remain the dominant form of reimbursement
in most markets. A recent poll found that 81 percent of health systems
and hospitals are participating in a mix of value-based reimbursement
models combined with fee-for-service.1 For the foreseeable future,
hospitals, health systems and other large provider organizations will
have a foot in two boats and the engines in both must be able to
run efficiently.

Login With

Related White Papers

Biomarkers and Acute Kidney Injury (AKI): Pre-analytical Considerations are Critical for Early Detection of AKI

By: Pacific Biomarkers

Biomarkers for the prediction of acute kidney injury: A review on current status and future challenges Biomarker of acute kidney injury (AKI) is strongly associated with increased morbidity and mortality in critically ill patients. The approach to analyzing AKI biomarkers has been to provide pharmaceutical and biotech companies with services for testing robust novel biomarkers that have undergone thorough analytical validation and clinical qualification with the expectation to diagnose early organ injury. Read this insightful whitepaper on ''Biomarkers for early detection of acute kidney injury'' to know more on: How to target biomarkers that can detect acute kidney injury (AKI) and what the potential of an AKI biomarker program is. What are the issues surrounding the best methods of collecting and storing urine used for detection of AKI in human subjects? Acute kidney injury biomarkers performance assesment 

Mastering the challenge of Digital Transformation

By: Software AG

Digital business transformation is based on an IT architecture transformation with a roadmap for digital capability implementation. Based on the software platforms, digital companies create enhanced or totally new business models which offer completely new digital customer experiences. Established companies are building up software know-how and are acquiring software companies to accelerate their digital transformation by injecting software innovation capabilities into their core business areas. This whitepaper helps to understand what makes today’s digital challengers attractive to customers and consumers, as it highlights their core competencies and differentiators based on their digital software-based technology. Key takeaways from this whitepaper: Digital challengers separate companies from their customers Implementing digital capabilities for digital use cases Digital companies have a micro services-oriented, scalable IT architecture

follow on linkedin follow on twitter follow on facebook 2020 All Rights Reserved | by: www.ciowhitepapersreview.com